Harigaya, H.; Chiba-Ohkuma, R.; Karakida, T.; Yamamoto, R.; Fujii-Abe, K.; Kawahara, H.; Yamakoshi, Y.
Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption. Int. J. Mol. Sci. 2024, 25, 7651.
https://doi.org/10.3390/ijms25147651
AMA Style
Harigaya H, Chiba-Ohkuma R, Karakida T, Yamamoto R, Fujii-Abe K, Kawahara H, Yamakoshi Y.
Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption. International Journal of Molecular Sciences. 2024; 25(14):7651.
https://doi.org/10.3390/ijms25147651
Chicago/Turabian Style
Harigaya, Hiroko, Risako Chiba-Ohkuma, Takeo Karakida, Ryuji Yamamoto, Keiko Fujii-Abe, Hiroshi Kawahara, and Yasuo Yamakoshi.
2024. "Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption" International Journal of Molecular Sciences 25, no. 14: 7651.
https://doi.org/10.3390/ijms25147651
APA Style
Harigaya, H., Chiba-Ohkuma, R., Karakida, T., Yamamoto, R., Fujii-Abe, K., Kawahara, H., & Yamakoshi, Y.
(2024). Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption. International Journal of Molecular Sciences, 25(14), 7651.
https://doi.org/10.3390/ijms25147651